Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

Mayo Clinic15,000 enrolled

Overview

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.

Study Type

OBSERVATIONAL

Enrollment

15,000

Conditions

Solid Tumors Hematologic Malignancies

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: 1. Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology 2. Radiation therapy for curative intent Exclusion Criteria: None

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States

RECRUITING

Outcomes

Primary Outcomes

analyze acute and late toxicities using CTCAE 4.03

Time frame: Patients will be followed for the duration of their life, an expected average of 20 years

analyze quality of life using LASA-3 and FACT-E

Time frame: Patients will be followed for the duration of their life, an expected average of 20 years

Secondary Outcomes

analyze local control through tumor assessments

Time frame: Patients will be followed for the duration of their life, an expected average of 20 years

analyze survival by contacting patient and EMR (electronic medical record) review

Time frame: Patients will be followed for the duration of their life, an expected average of 20 years

Central Contacts

Clinical Trials Referral Office

CONTACT

855-776-0015 mayocliniccancerstudies@mayo.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.